Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 10, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$15.6B
sum of reported positions
Reported positions
364
Changes vs prior quarter
351
80 new · 78 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 164 measured positions in 8 quarters, the typical new or larger position finished −2.7 pts against the S&P 500 and 45% finished ahead of it. For scale, across all 503 funds with a result: −2.1 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
343 institutions report a stake; Migdal Insurance & Financial Holdings Ltd. is the #3 holder.
Also among the 20 largest: Harel Insurance Investments & Financial Services Ltd., Menora Mivtachim Holdings Ltd., Clal Insurance Enterprises Holdings Ltd
6,246 institutions report a stake.
Also among the 20 largest: Capital World Investors, Berkshire Hathaway,
| Company | Shares | Value | Weight | Of company |
|---|---|---|---|---|
TEVA PHARMACEUTICAL INDS LTD | $1.32B | 8.4% | — | |
SELECT SECTOR SPDR TR | $1.08B | 6.9% | — | |
SELECT SECTOR SPDR TR | $918M | 5.9% | — | |
| $880M | 5.6% | — | ||
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
In its latest 13F, with holdings as of Jun 30, 2026 (Q2 2026), Migdal Insurance & Financial Holdings Ltd. reported 364 positions worth $15.6B. The largest: TEVA PHARMACEUTICAL INDS LTD, 8.4%; SELECT SECTOR SPDR TR, 6.9%; SELECT SECTOR SPDR TR, 5.9%; Nova (NVMI), 5.6%; Alphabet (GOOGL), 5.0%. The five largest make up 32% of the reported portfolio.
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $11.5B | $15.6B |
| Positions | 362 | 364 |
| Biggest line | — | TEVA PHARMACEUTICAL INDS LTD 8% |
5,947 institutions report a stake.
Also among the 20 largest: Capital Research Global Investors
450 institutions report a stake; Migdal Insurance & Financial Holdings Ltd. is the #9 holder.
Also among the 20 largest: Clal Insurance Enterprises Holdings Ltd, Phoenix Financial Ltd., Harel Insurance Investments & Financial Services Ltd.
6,117 institutions report a stake.
Also among the 20 largest: Capital Research Global Investors, Capital World Investors
234 institutions report a stake; Migdal Insurance & Financial Holdings Ltd. is the #1 holder.
Also among the 20 largest: Harel Insurance Investments & Financial Services Ltd., Wasatch Advisors LP, Menora Mivtachim Holdings Ltd.

| $787M |
| 5.0% |
| 0.02% |
VANECK ETF TRUST | $651M | 4.2% | — |
| $505M | 3.2% | 0.01% |
| $451M | 2.9% | 1.5% |
| $446M | 2.9% | 0.02% |
| $432M | 2.8% | 5.8% |
SELECT SECTOR SPDR TR | $379M | 2.4% | — |
SELECT SECTOR SPDR TR | $365M | 2.3% | — |
| $353M | 2.3% | 0.01% |
| $310M | 2.0% | 0.01% |
| $292M | 1.9% | 0.02% |
| $276M | 1.8% | 0.02% |
| $254M | 1.6% | 0.04% |
| $249M | 1.6% | 0.09% |
INVESCO EXCH TRADED FD TR II | $246M | 1.6% | — |
SELECT SECTOR SPDR TR | $244M | 1.6% | — |
| $234M | 1.5% | 0.00% |
ISHARES TR | $214M | 1.4% | — |
ISHARES INC | $207M | 1.3% | — |
| $167M | 1.1% | 0.03% |
| $164M | 1.0% | 0.01% |
INVESCO EXCH TRD SLF IDX FD
47K → 37K shares (−21%)
ON Semiconductor (ON)
816 → 7,895 shares (+868%)
FRANKLIN TEMPLETON ETF TR
4,200 → 8,400 shares (+100%)
TJX Companies (TJX)
5,590 → 4,688 shares (−16%)
Icici Bank (IBN)
29K → 24K shares (−17%)
FIRST TR EXCHANGE-TRADED FD
4,598 → 4,408 shares (−4%)
ISHARES TR
31K → 28K shares (−12%)
DIREXION SHARES ETF TRUST
5,647 → 5,377 shares (−5%)
Microchip Technology (MCHP)
457K → 7,460 shares (−98%)
ConocoPhillips (COP)
7,282 → 6,123 shares (−16%)
Cadence Design Systems (CDNS)
1,484 → 1,670 shares (+13%)
FIRST TR EXCH TRD ALPHDX FD
6,500 → 13K shares (+100%)
Qualys (QLYS)
4,487 → 4,000 shares (−11%)
PETROLEO BRASILEIRO S A
15K → 29K shares (+100%)
Kroger (KR)
11K → 9,582 shares (−14%)
ITAU UNIBANCO HLDG S A
32K → 64K shares (+100%)
SCHWAB STRATEGIC TR
19K → 15K shares (−21%)
Akamai Technologies (AKAM)
4,000 → 4,192 shares (+5%)
EXCHANGE TRADED CONCEPTS TRU
14K → 13K shares (−8%)
VANGUARD SCOTTSDALE FDS
4,802 → 5,990 shares (+25%)
INVESCO EXCH TRADED FD TR II
6,540 shares
T-Mobile (TMUS)
2,768 → 2,631 shares (−5%)
AIRSHIP AI HLDGS INC
573K shares
GOLDMAN SACHS ETF TR
4,825 → 4,225 shares (−12%)
Johnson & Johnson (JNJ)
1,553 → 1,580 shares (+2%)
TEVA PHARMACEUTICAL INDS LTD: $1.32B, or 8.4% of the portfolio reported for Q2 2026.
Between its last two 13F reports, Migdal Insurance & Financial Holdings Ltd. opened 80 new positions, added to 103, trimmed 90 and sold out of 78. The comparison is in share counts, so a price move alone does not count as buying or selling.
Its 13F for Q2 2026 adds up to $15.6B. That is not the whole firm: a 13F lists only US-listed shares and some options held at the end of the quarter, and leaves out cash, bonds, short positions and foreign holdings.
The report for Q2 2026 was filed on Aug 10, 2026. A manager has 45 days after the end of each quarter to file, so the holdings are always several weeks old when they become public.
On 164 positions it reported as new or larger over 8 quarters, the typical one finished −2.7 points against the S&P 500 after 90 days, and 45% finished ahead of it. Measured from the day each filing became public; history, not a forecast.
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.